Chicago, IL (April 1, 2022) – RiverGlade Capital (“RiverGlade”), a healthcare-focused private equity firm, is excited to welcome Jim Robison to the firm as an Operating Partner. Jim is a member of RiverGlade’s Executive Healthcare Advisory Council and has served in board-level roles at both U.S. Oral Surgery Management and TenderHeart Health Outcomes where he is currently Chairman of the Board. This new role provides the opportunity to leverage Jim’s strategic insight more broadly across the RiverGlade’s partners and investments.

On behalf of the firm, Managing Partners Garrick Rice and Danny Rosenberg noted, “We’re excited to continue working with Jim in this expanded capacity. His contributions and leadership over the years have proven invaluable, and we look forward to his added impact on growth in our portfolio.”

Jim formerly served as the Chairman, President and Chief Executive Officer of Animal Health International and prior to that spent sixteen years in the medical supply and device industry with American Hospital Supply, General Medical Corporation, and McKesson. Throughout his career, Jim has driven growth and professionalization at companies utilizing data-driven performance optimization, systems and operational improvements, sales and marketing disciplines, and talent training and development. Jim holds an undergraduate business degree from the University of Texas at Austin and a Masters in International Business from University of Texas at Dallas.

ABOUT RIVERGLADE CAPITAL

RiverGlade Capital is a private equity firm focused on control buyouts of growth-oriented, lower middle market healthcare companies. RiverGlade partners with founder-owned, high-quality, differentiated businesses that have demonstrated strong organic growth and where value can be accelerated through human capital investments, operational improvements, strategic planning, and dynamic organic and inorganic growth initiatives. For more information, visit www.rivergladecapital.com.